Literature DB >> 27532

Human erythrocyte hexokinase deficiency. Characterization of a mutant enzyme with abnormal regulatory properties.

G Rijksen, G E Staal.   

Abstract

In the erythrocytes of a patient with hereditary nonspherocytic hemolytic anemia, a homozygous expression of hexokinase deficiency was detected. The mutant enzyme was characterized by normal kinetic parameters with respect to its substrates, glucose and MgATP2-, normal pH optimum, normal heat stability at 40 degrees C, but abnormal behavior with respect to its regulation by glucose-1,6-diphosphate and inorganic phosphate, and an altered electrophoretic pattern. Interpretation of the results revealed the presence of two different hexokinases type I in normal human erythrocytes: one enzyme with a high affinity for glucose-1,6-diphosphate, the inhibition of which is regulated by inorganic phosphate; and another enzyme with a lower affinity for the inhibitor, not regulated by inorganic phosphate. The former enzyme was not detectable in the erythrocytes of the patient, whereas the presence of the latter enzyme could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27532      PMCID: PMC371766          DOI: 10.1172/JCI109129

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  The removal of leukocytes and platelets from whole blood.

Authors:  E Beutler; C West; K G Blume
Journal:  J Lab Clin Med       Date:  1976-08

2.  Hemolytic anemia and hexokinase deficiency associated with malformations.

Authors:  K M Goebel; W D Gassel; F D Goebel; H Kaffarnik
Journal:  Klin Wochenschr       Date:  1972-09-01

3.  Erythrocyte hexokinase isoenzyme patterns in hereditary hemoglobinopathies.

Authors:  J I Malone; A I Winegrad; F A Oski; E W Holmes
Journal:  N Engl J Med       Date:  1968-11-14       Impact factor: 91.245

4.  [Hexokinase deficiency in hemolytic anemia].

Authors:  K Moser; M Ciresa; J Schwarzmeier
Journal:  Med Welt       Date:  1970-11-14

5.  Multiple forms of hexokinase in the rat: tissue distribution, age dependency, and properties.

Authors:  H M Katzen; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1965-10       Impact factor: 11.205

6.  Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate.

Authors:  G Rijksen; G E Staal
Journal:  Biochim Biophys Acta       Date:  1977-11-23

7.  [Hexokinase deficiency in blood cells in a group of kin with familial panmyelopathy (Fanconi type)].

Authors:  G W Löhr; H D Waller; F Anschütz; A Knopp
Journal:  Klin Wochenschr       Date:  1965-08-15

8.  Hereditary hemolytic anemia with hexokinase deficiency. Role of hexokinase in erythrocyte aging.

Authors:  W N Valentine; F A Oski; D E Paglia; M A Baughan; A S Schneider; J L Naiman
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

9.  An examination of the age-related patterns of decay of the hexokinases of human red cells.

Authors:  P A Rogers; R A Fisher; H Harris
Journal:  Clin Chim Acta       Date:  1975-12-15       Impact factor: 3.786

10.  Purification and some properties of human erythrocyte hexokinase.

Authors:  G Rijksen; G E Staal
Journal:  Biochim Biophys Acta       Date:  1976-09-14
View more
  3 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  The relationship between homozygosity level and animal physiology: iron content of plasma and whole blood as well as total iron binding capacity by transferrin (TIBC) in rats of various inbreeding coefficient.

Authors:  B Kosowska
Journal:  Biochem Genet       Date:  1992-08       Impact factor: 1.890

3.  Erythrocytes as bioreactors to decrease excess ammonium concentration in blood.

Authors:  Eugeniy S Protasov; Daria V Borsakova; Yuliya G Alexandrovich; Anatoliy V Korotkov; Elena A Kosenko; Andrey A Butylin; Fazoil I Ataullakhanov; Elena I Sinauridze
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.